ORBIMED ADVISORS LLC

PrivateCIK: 1055951
Location

NEW YORK, NY

Insider sale

PASSAGE BIO, INC.

$1.44M

1.28M shares

What this filing means

ORBIMED ADVISORS LLC plans to sell 1.28M shares of PASSAGE BIO, INC. valued at approximately $1.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderORBIMED ADVISORS LLCCIK 1055951
IssuerPASSAGE BIO, INC.CIK 1787297
10% Owner
Since Feb 2020
1.28M
Shares to sell
$1.44M
Approx. market value
132.65K
Acquired (3 months)
1
Planned
15 completed
Securities Acquired — Last 3 Months1
Sort

IPO

N/A

3/3/2020
132.65K
Total acquired132.65K
Planned & Completed Dispositions16
Sort

Completed

Completed

Units to sell

7.36K

Market value

$41.9K

7/18/2025
Completed

Units to sell

22.19K

Market value

$129.4K

7/17/2025
Completed

Units to sell

20.05K

Market value

$117.5K

7/16/2025
Completed

Units to sell

3.70K

Market value

$25.0K

7/15/2025
Completed

Units to sell

127.23K

Market value

$50.9K

7/10/2025
Completed

Units to sell

57.11K

Market value

$25.1K

7/9/2025
Completed

Units to sell

50.70K

Market value

$21.8K

7/8/2025
Completed

Units to sell

23.96K

Market value

$11.5K

7/7/2025
Completed

Units to sell

11.04K

Market value

$3.8K

6/27/2025
Completed

Units to sell

213.26K

Market value

$70.4K

6/26/2025
Completed

Units to sell

138.80K

Market value

$45.8K

6/25/2025
Completed

Units to sell

231.60K

Market value

$81.1K

6/24/2025
Completed

Units to sell

68.19K

Market value

$21.8K

4/24/2025
Completed

Units to sell

89.33K

Market value

$30.4K

4/23/2025
Completed

Units to sell

78.05K

Market value

$26.5K

4/22/2025

Planned — Approximate Date

Nasdaq Stock MarketPlanned

Units to sell

132.65K

Market value

$737.5K

7/21/2025
Total

Units

1.28M

Value

$1.44M

ORBIMED ADVISORS LLC — Planned Insider Sale (Form 144) | Finecho